首页> 外文期刊>Human Genetics >Identification of signal peptide domain SOST mutations in autosomal dominant craniodiaphyseal dysplasia.
【24h】

Identification of signal peptide domain SOST mutations in autosomal dominant craniodiaphyseal dysplasia.

机译:常染色体显性遗传性颅骨干异常发育中信号肽域SOST突变的鉴定。

获取原文
获取原文并翻译 | 示例
       

摘要

Sclerosteosis and Van Buchem disease are related recessive sclerosing bone dysplasias caused by alterations in the SOST gene. We tested the hypothesis that craniodiaphyseal dysplasia (CDD) (MIM 122860), an extremely rare sclerosing bone dysplasia resulting facial distortion referred to as "leontiasis ossea", could also be caused by SOST mutations. We discovered mutations c.61G>A (Val21Met) and c.61G>T (Val21Leu) two children with CDD. As these mutations are located in the secretion signal of the SOST gene, we tested their effect on secretion by transfecting the mutant constructs into 293E cells. Intriguingly, these mutations greatly reduced the secretion of SOST. We conclude that CDD, the most severe form of sclerotic bone disease, is part of a spectrum of disease caused by mutations in SOST. Unlike the other SOST-related conditions, sclerosteosis and Van Buchem disease that are inherited as recessive traits seem to be caused by a dominant negative mechanism.
机译:硬化症和范布赫姆病是由SOST基因改变引起的隐性硬化性骨隐性发育不良。我们测试了以下假设:颅骨干phy发育不良(CDD)(MIM 122860)是一种极为罕见的硬化性骨发育异常,可导致面部畸形,称为“软骨病性腰椎病”,也可能由SOST突变引起。我们发现了两名患有CDD的儿童的突变c.61G> A(Val21Met)和c.61G> T(Val21Leu)。由于这些突变位于SOST基因的分泌信号中,我们通过将突变体构建体转染到293E细胞中来测试它们对分泌的影响。有趣的是,这些突变大大减少了SOST的分泌。我们得出结论,CDD是硬化性骨病的最严重形式,是SOST突变引起的一系列疾病的一部分。与其他与SOST相关的疾病不同,作为隐性遗传的硬化性硬化症和Van Buchem病似乎是由主要的负性机制引起的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号